Global Information
회사소개 | 문의 | 비교리스트

세계의 다낭성 신장질환(PKD) 치료제 시장(2022-2026년)

Global Polycystic Kidney Disease Drugs Market 2022-2026

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2022년 07월 상품코드 1105327
페이지 정보 영문 120 Pages 배송안내
가격
US $ 2,500 ₩ 3,276,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 5,242,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 다낭성 신장질환(PKD) 치료제 시장(2022-2026년) Global Polycystic Kidney Disease Drugs Market 2022-2026
발행일 : 2022년 07월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 다낭성 신장질환(PKD) 치료제 시장 규모는 2022-2026년간 5억 1,069만 달러 증가할 전망이며, 예측 기간에 연평균 복합 성장률(CAGR) 6.7%의 성장이 예측됩니다.

만성 신장병의 높은 유병률, 특별한 규제 지정, 신약 개발을 위한 연구개발 증가가 시장 성장의 원동력이 되고 있습니다.

세계의 다낭성 신장질환(PKD: Polycystic Kidney Disease) 치료제 시장에 대해 조사분석했으며, 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 정보를 제공합니다.

목차

제1장 개요

  • 시장 개요

제2장 시장 구도

  • 시장 생태계

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 : 2021년
  • 시장 전망 : 2021-2026년 예측

제4장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급업체의 교섭력
  • 신규 기업의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 현황

제5장 시장 세분화 : 유형별

  • 시장 부문
  • 비교 : 유형별
  • ADPKD - 시장 규모와 예측(2021-2026년)
  • ARPKD - 시장 규모와 예측(2021-2026년)
  • 시장 기회 : 유형별

제6장 고객 상황

  • 고객 상황 개요

제7장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 - 시장 규모와 예측(2021-2026년)
  • 유럽 - 시장 규모와 예측(2021-2026년)
  • 아시아 - 시장 규모와 예측(2021-2026년)
  • 기타 지역(ROW) - 시장 규모와 예측(2021-2026년)
  • 미국 - 시장 규모와 예측(2021-2026년)
  • 독일 - 시장 규모와 예측(2021-2026년)
  • 중국 - 시장 규모와 예측(2021-2026년)
  • 영국 - 시장 규모와 예측(2021-2026년)
  • 캐나다 - 시장 규모와 예측(2021-2026년)
  • 시장 기회 : 지역 상황별

제8장 시장 성장 촉진요인, 과제 및 동향

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 시장 성장 촉진요인과 과제의 영향
  • 시장 동향

제9장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란 상황
  • 업계 리스크

제10장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • AstraZeneca Plc
  • Galapagos NV
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Otsuka Holdings Co. Ltd.
  • Palladio Biosciences Inc.
  • Reata Pharmaceuticals Inc.
  • Regulus Therapeutics Inc.
  • Sanofi
  • XORTX Therapeutics Inc.

제11장 부록

LSH 22.08.02

Technavio has been monitoring the polycystic kidney disease drugs market and it is poised to grow by $ 510.69 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the polycystic kidney disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of chronic kidney diseases, special regulatory designations, and increasing R&D for developing new drugs.

The polycystic kidney disease drugs market analysis includes type segment and geographic landscape.

Technavio's polycystic kidney disease drugs market is segmented as below:

By Type

  • ADPKD
  • ARPKD

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing research funding as one of the prime reasons driving the polycystic kidney disease drugs market growth during the next few years. Also, favorable reimbursement policies and growing awareness about kidney diseases will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the polycystic kidney disease drugs market covers the following areas:

  • Polycystic kidney disease drugs market sizing
  • Polycystic kidney disease drugs market forecast
  • Polycystic kidney disease drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading polycystic kidney disease drugs market vendors that include Apotex Inc., AstraZeneca Plc, Dr. Reddys Laboratories Ltd., Galapagos NV, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Palladio Biosciences Inc., Reata Pharmaceuticals Inc., Regulus Therapeutics Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and XORTX Therapeutics Inc. Also, the polycystic kidney disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 ADPKD - Market size and forecast 2021-2026
  • Exhibit 28: Chart on ADPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on ADPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on ADPKD - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on ADPKD - Year-over-year growth 2021-2026 (%)
  • 5.4 ARPKD - Market size and forecast 2021-2026
  • Exhibit 32: Chart on ARPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on ARPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on ARPKD - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on ARPKD - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Type
  • Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 AstraZeneca Plc
  • Exhibit 85: AstraZeneca Plc - Overview
  • Exhibit 86: AstraZeneca Plc - Product / Service
  • Exhibit 87: AstraZeneca Plc - Key news
  • Exhibit 88: AstraZeneca Plc - Key offerings
  • 10.4 Galapagos NV
  • Exhibit 89: Galapagos NV - Overview
  • Exhibit 90: Galapagos NV - Product / Service
  • Exhibit 91: Galapagos NV - Key offerings
  • 10.5 Johnson and Johnson
  • Exhibit 92: Johnson and Johnson - Overview
  • Exhibit 93: Johnson and Johnson - Business segments
  • Exhibit 94: Johnson and Johnson - Key news
  • Exhibit 95: Johnson and Johnson - Key offerings
  • Exhibit 96: Johnson and Johnson - Segment focus
  • 10.6 Merck and Co. Inc.
  • Exhibit 97: Merck and Co. Inc. - Overview
  • Exhibit 98: Merck and Co. Inc. - Business segments
  • Exhibit 99: Merck and Co. Inc. - Key news
  • Exhibit 100: Merck and Co. Inc. - Key offerings
  • Exhibit 101: Merck and Co. Inc. - Segment focus
  • 10.7 Otsuka Holdings Co. Ltd.
  • Exhibit 102: Otsuka Holdings Co. Ltd. - Overview
  • Exhibit 103: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibit 104: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibit 105: Otsuka Holdings Co. Ltd. - Segment focus
  • 10.8 Palladio Biosciences Inc.
  • Exhibit 106: Palladio Biosciences Inc. - Overview
  • Exhibit 107: Palladio Biosciences Inc. - Product / Service
  • Exhibit 108: Palladio Biosciences Inc. - Key offerings
  • 10.9 Reata Pharmaceuticals Inc.
  • Exhibit 109: Reata Pharmaceuticals Inc. - Overview
  • Exhibit 110: Reata Pharmaceuticals Inc. - Product / Service
  • Exhibit 111: Reata Pharmaceuticals Inc. - Key offerings
  • 10.10 Regulus Therapeutics Inc.
  • Exhibit 112: Regulus Therapeutics Inc. - Overview
  • Exhibit 113: Regulus Therapeutics Inc. - Product / Service
  • Exhibit 114: Regulus Therapeutics Inc. - Key offerings
  • 10.11 Sanofi
  • Exhibit 115: Sanofi - Overview
  • Exhibit 116: Sanofi - Business segments
  • Exhibit 117: Sanofi - Key news
  • Exhibit 118: Sanofi - Key offerings
  • Exhibit 119: Sanofi - Segment focus
  • 10.12 XORTX Therapeutics Inc.
  • Exhibit 120: XORTX Therapeutics Inc. - Overview
  • Exhibit 121: XORTX Therapeutics Inc. - Product / Service
  • Exhibit 122: XORTX Therapeutics Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 123: Inclusions checklist
  • Exhibit 124: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 125: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 126: Research methodology
  • Exhibit 127: Validation techniques employed for market sizing
  • Exhibit 128: Information sources
  • 11.5 List of abbreviations
  • Exhibit 129: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Type
  • Exhibits27: Data Table on Comparison by Type
  • Exhibits28: Chart on ADPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on ADPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on ADPKD - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on ADPKD - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on ARPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on ARPKD - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on ARPKD - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on ARPKD - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Type ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: AstraZeneca Plc - Overview
  • Exhibits86: AstraZeneca Plc - Product / Service
  • Exhibits87: AstraZeneca Plc - Key news
  • Exhibits88: AstraZeneca Plc - Key offerings
  • Exhibits89: Galapagos NV - Overview
  • Exhibits90: Galapagos NV - Product / Service
  • Exhibits91: Galapagos NV - Key offerings
  • Exhibits92: Johnson and Johnson - Overview
  • Exhibits93: Johnson and Johnson - Business segments
  • Exhibits94: Johnson and Johnson - Key news
  • Exhibits95: Johnson and Johnson - Key offerings
  • Exhibits96: Johnson and Johnson - Segment focus
  • Exhibits97: Merck and Co. Inc. - Overview
  • Exhibits98: Merck and Co. Inc. - Business segments
  • Exhibits99: Merck and Co. Inc. - Key news
  • Exhibits100: Merck and Co. Inc. - Key offerings
  • Exhibits101: Merck and Co. Inc. - Segment focus
  • Exhibits102: Otsuka Holdings Co. Ltd. - Overview
  • Exhibits103: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibits104: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibits105: Otsuka Holdings Co. Ltd. - Segment focus
  • Exhibits106: Palladio Biosciences Inc. - Overview
  • Exhibits107: Palladio Biosciences Inc. - Product / Service
  • Exhibits108: Palladio Biosciences Inc. - Key offerings
  • Exhibits109: Reata Pharmaceuticals Inc. - Overview
  • Exhibits110: Reata Pharmaceuticals Inc. - Product / Service
  • Exhibits111: Reata Pharmaceuticals Inc. - Key offerings
  • Exhibits112: Regulus Therapeutics Inc. - Overview
  • Exhibits113: Regulus Therapeutics Inc. - Product / Service
  • Exhibits114: Regulus Therapeutics Inc. - Key offerings
  • Exhibits115: Sanofi - Overview
  • Exhibits116: Sanofi - Business segments
  • Exhibits117: Sanofi - Key news
  • Exhibits118: Sanofi - Key offerings
  • Exhibits119: Sanofi - Segment focus
  • Exhibits120: XORTX Therapeutics Inc. - Overview
  • Exhibits121: XORTX Therapeutics Inc. - Product / Service
  • Exhibits122: XORTX Therapeutics Inc. - Key offerings
  • Exhibits123: Inclusions checklist
  • Exhibits124: Exclusions checklist
  • Exhibits125: Currency conversion rates for US$
  • Exhibits126: Research methodology
  • Exhibits127: Validation techniques employed for market sizing
  • Exhibits128: Information sources
  • Exhibits129: List of abbreviations
Back to Top
전화 문의
F A Q